Clinical Trial Update: Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission [Phase 1]

View source ↗

Summary

Phase 1 trial assessing berberine chloride to prevent colorectal cancer in patients with ulcerative colitis in remission has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Ulcerative Colitis

Drugs mentioned

• Berberine chloride (berberine chloride)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Ulcerative Colitis | Phase 1 | Status: COMPLETED | Results posted: 2021-06-02